Global Myeloproliferative Disorders Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 122 pages | ID: GE7E9C7A0EDGEN
GlobalInfoResearch

Abstracts

hronic myeloproliferative disorders are rare hematological malignances that involve abnormal accumulation of mature myeloid cells (red blood cells, granulocytes, and platelets) and their precursors (myelocytes, metamyelocytes, nucleated red blood cells, and megakaryocytes) in the peripheral blood and bone marrow.

SCOPE OF THE REPORT:

This report studies the Myeloproliferative Disorders Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Myeloproliferative Disorders Drugs market by product type and applications/end industries.
The available drugs have not shown disease-modifying activity and are still largely inadequate for managing major unmet needs, which include prevention of hematological progression, normalization of life span, reduction of cardiovascular complications, and improved quality of life. Strong unmet needs within the market present a key opportunity to develop breakthrough first-in-class therapies.
The global Myeloproliferative Disorders Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Myeloproliferative Disorders Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Celgene
• Bristol-Myers Squibb
• Gamida Cell
• Incyte
• Geron
• Promedior
• Johnson & Johnson

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Ph+ CML
• Ph- MPN

Market Segment by Applications, can be divided into

• Hospitals
• Pharmacy

Contents

1 MYELOPROLIFERATIVE DISORDERS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Myeloproliferative Disorders Drugs
1.2 Classification of Myeloproliferative Disorders Drugs by Types
  1.2.1 Global Myeloproliferative Disorders Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Myeloproliferative Disorders Drugs Revenue Market Share by Types in 2017
  1.2.3 Ph+ CML
  1.2.4 Ph- MPN
1.3 Global Myeloproliferative Disorders Drugs Market by Application
  1.3.1 Global Myeloproliferative Disorders Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Pharmacy
1.4 Global Myeloproliferative Disorders Drugs Market by Regions
  1.4.1 Global Myeloproliferative Disorders Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Myeloproliferative Disorders Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Myeloproliferative Disorders Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Myeloproliferative Disorders Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Myeloproliferative Disorders Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Myeloproliferative Disorders Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Myeloproliferative Disorders Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Celgene
  2.1.1 Business Overview
  2.1.2 Myeloproliferative Disorders Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Celgene Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
  2.2.1 Business Overview
  2.2.2 Myeloproliferative Disorders Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Bristol-Myers Squibb Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Gamida Cell
  2.3.1 Business Overview
  2.3.2 Myeloproliferative Disorders Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Gamida Cell Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Incyte
  2.4.1 Business Overview
  2.4.2 Myeloproliferative Disorders Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Incyte Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Geron
  2.5.1 Business Overview
  2.5.2 Myeloproliferative Disorders Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Geron Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Promedior
  2.6.1 Business Overview
  2.6.2 Myeloproliferative Disorders Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Promedior Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
  2.7.1 Business Overview
  2.7.2 Myeloproliferative Disorders Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Johnson & Johnson Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL MYELOPROLIFERATIVE DISORDERS DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Myeloproliferative Disorders Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Myeloproliferative Disorders Drugs Players Market Share
  3.2.2 Top 10 Myeloproliferative Disorders Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL MYELOPROLIFERATIVE DISORDERS DRUGS MARKET SIZE BY REGIONS

4.1 Global Myeloproliferative Disorders Drugs Revenue and Market Share by Regions
4.2 North America Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA MYELOPROLIFERATIVE DISORDERS DRUGS REVENUE BY COUNTRIES

5.1 North America Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
5.2 USA Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE MYELOPROLIFERATIVE DISORDERS DRUGS REVENUE BY COUNTRIES

6.1 Europe Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
6.2 Germany Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
6.4 France Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC MYELOPROLIFERATIVE DISORDERS DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
7.2 China Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
7.5 India Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA MYELOPROLIFERATIVE DISORDERS DRUGS REVENUE BY COUNTRIES

8.1 South America Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
8.2 Brazil Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE MYELOPROLIFERATIVE DISORDERS DRUGS BY COUNTRIES

9.1 Middle East and Africa Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL MYELOPROLIFERATIVE DISORDERS DRUGS MARKET SEGMENT BY TYPE

10.1 Global Myeloproliferative Disorders Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Myeloproliferative Disorders Drugs Market Forecast by Type (2018-2023)
10.3 Ph+ CML Revenue Growth Rate (2013-2023)
10.4 Ph- MPN Revenue Growth Rate (2013-2023)

11 GLOBAL MYELOPROLIFERATIVE DISORDERS DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Myeloproliferative Disorders Drugs Revenue Market Share by Application (2013-2018)
11.2 Myeloproliferative Disorders Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Pharmacy Revenue Growth (2013-2018)

12 GLOBAL MYELOPROLIFERATIVE DISORDERS DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Myeloproliferative Disorders Drugs Market Size Forecast (2018-2023)
12.2 Global Myeloproliferative Disorders Drugs Market Forecast by Regions (2018-2023)
12.3 North America Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
12.6 South America Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Myeloproliferative Disorders Drugs Picture
Table Product Specifications of Myeloproliferative Disorders Drugs
Table Global Myeloproliferative Disorders Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Myeloproliferative Disorders Drugs Revenue Market Share by Types in 2017
Figure Ph+ CML Picture
Figure Ph- MPN Picture
Table Global Myeloproliferative Disorders Drugs Revenue (Million USD) by Application (2013-2023)
Figure Myeloproliferative Disorders Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Pharmacy Picture
Table Global Market Myeloproliferative Disorders Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Myeloproliferative Disorders Drugs Type and Applications
Table Celgene Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Myeloproliferative Disorders Drugs Type and Applications
Table Bristol-Myers Squibb Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Gamida Cell Basic Information, Manufacturing Base and Competitors
Table Gamida Cell Myeloproliferative Disorders Drugs Type and Applications
Table Gamida Cell Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Incyte Basic Information, Manufacturing Base and Competitors
Table Incyte Myeloproliferative Disorders Drugs Type and Applications
Table Incyte Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Geron Basic Information, Manufacturing Base and Competitors
Table Geron Myeloproliferative Disorders Drugs Type and Applications
Table Geron Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Promedior Basic Information, Manufacturing Base and Competitors
Table Promedior Myeloproliferative Disorders Drugs Type and Applications
Table Promedior Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Myeloproliferative Disorders Drugs Type and Applications
Table Johnson & Johnson Myeloproliferative Disorders Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Myeloproliferative Disorders Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue Share by Players (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Share by Players in 2016
Figure Global Myeloproliferative Disorders Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Myeloproliferative Disorders Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Myeloproliferative Disorders Drugs Revenue Market Share in 2017
Figure Global Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Market Share by Regions in 2017
Figure North America Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure South America Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Table North America Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
Table North America Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Myeloproliferative Disorders Drugs Revenue Market Share by Countries in 2017
Figure USA Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Table Europe Myeloproliferative Disorders Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Myeloproliferative Disorders Drugs Revenue Market Share by Countries in 2017
Figure Germany Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure UK Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure France Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Myeloproliferative Disorders Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Myeloproliferative Disorders Drugs Revenue Market Share by Countries in 2017
Figure China Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure India Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Table South America Myeloproliferative Disorders Drugs Revenue by Countries (2013-2018)
Table South America Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Myeloproliferative Disorders Drugs Revenue Market Share by Countries in 2017
Figure Brazil Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Myeloproliferative Disorders Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Myeloproliferative Disorders Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Myeloproliferative Disorders Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Myeloproliferative Disorders Drugs Revenue and Growth Rate (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue Share by Type (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Share by Type (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Share by Type in 2017
Table Global Myeloproliferative Disorders Drugs Revenue Forecast by Type (2018-2023)
Figure Global Myeloproliferative Disorders Drugs Market Share Forecast by Type (2018-2023)
Figure Global Ph+ CML Revenue Growth Rate (2013-2018)
Figure Global Ph- MPN Revenue Growth Rate (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue by Application (2013-2018)
Table Global Myeloproliferative Disorders Drugs Revenue Share by Application (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Share by Application (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue Share by Application in 2017
Table Global Myeloproliferative Disorders Drugs Revenue Forecast by Application (2018-2023)
Figure Global Myeloproliferative Disorders Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Pharmacy Revenue Growth Rate (2013-2018)
Figure Global Myeloproliferative Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Myeloproliferative Disorders Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Myeloproliferative Disorders Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
Figure Europe Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
Figure South America Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Myeloproliferative Disorders Drugs Revenue Market Forecast (2018-2023)